期刊文献+

真性红细胞增多症后骨髓纤维化转变为急性髓系白血病并发非霍奇金淋巴瘤一例 被引量:1

原文传递
导出
摘要 患者 男,75岁,1987年因“感冒”查血常规:白细胞计数(WBC) 12.3×10^9/L,血红蛋白(Hb)216 g/L,血小板计数(Ph)2070×10^9/L.B型超声示肝脾大.骨髓穿刺示:骨髓增生极度活跃.诊断为骨髓增殖性疾病.曾在外院接受静脉30P1个疗程治疗.1990年4月至7月间断服用白消安控制血象.1990年9月19日血常规:WBC 14.8×10^9/L,Hb 223 g/L,Plt73×10^9/L.人北京大学第一医院住院治疗.
出处 《白血病.淋巴瘤》 CAS 2014年第3期191-192,共2页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献12

  • 1Finazzi G, Cruso V, Marchinli R, et al. Acute leukemia in Polyeythemia vera an analysis of 1638 patients enrolled in a prospective observational study[J]. Blood, 2005, 105: 2664-2670.
  • 2Barosi G, Mesa RA, Thiele J, et al. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment[J]. Leukemia, 2008, 22: 437-438.
  • 3Passamonti F, Rumi E, Pungolino E, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia[J]. Am J Med, 2004, 117: 755-761.
  • 4Passamonti F, Malabarba L, Orlandi E, et al. Polycythemia vera in young palients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia[J]. Haematolngica, 2003, 88:13-18.
  • 5Steensma DP, Dewald GW, Lasho TL, et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both atypical myeloproliferative disorders and myelodysplastic syndromes [J]. Blood, 2005, 106: 1207-1209.
  • 6Szpurka H, Tiu R, Murugesan G, et al. Refractory anemia with ringed sideroblastes associated with Marked thrombocytosis (RARST), another myelooproliferative condition characterized by JAK2 V617F. Mutation[J]. Blood, 2006, 108: 2173-2181.
  • 7Villeval JL, James C, Pisani DF, et al. New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients [J]. Semin Thromb Hemost, 2006, 32:341-351.
  • 8Najean Y, Rain JD, Dresch C, et al. Risk of leukaemia, carcinoma and myelofibrosis in 32P- or chemotherapy-treatment patients with polycythmia vera : a prospective analysis of 682 cases, The 'French Cooperative Group for the study of polycythaemias' [J]. Leuk Lymphoma, 1996, 22:111-119.
  • 9Murphy S, Peterson P, Iland H, et al. Experience of the polycythemia vera study group with essentional thrombocythemia, a fin~il report on diagnostic criteria survival and Leukemic transition by treatment [J]. Sem in Hematol, 1997, 34: 29-39.
  • 10Castellano S, Carbone M, Carrozzo M, et al. Onset of oral extranodal large B-ceil non-Hodgkin's lymphoma in a patient with polycythemia vera: a rare presentation[J]. Oral Oncol, 2002, 38: 624-626.

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部